These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23314853)

  • 1. NK4 gene therapy inhibits HGF/Met-induced growth of human cholangiocarcinoma cells.
    Ge X; Wang Y; Wang Y; Li Q; Yu H; Miao L
    Dig Dis Sci; 2013 Jun; 58(6):1636-43. PubMed ID: 23314853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NK4 regulates 5-fluorouracil sensitivity in cholangiocarcinoma cells by modulating the intrinsic apoptosis pathway.
    Ge X; Wang Y; Li Q; Yu H; Ji G; Miao L
    Oncol Rep; 2013 Jul; 30(1):448-54. PubMed ID: 23619566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of c-Met/hepatocyte growth factor pathway in cholangiocarcinoma cell invasion and its therapeutic inhibition with small interfering RNA specific for c-Met.
    Leelawat K; Leelawat S; Tepaksorn P; Rattanasinganchan P; Leungchaweng A; Tohtong R; Sobhon P
    J Surg Res; 2006 Nov; 136(1):78-84. PubMed ID: 16950403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NK4 gene therapy targeting HGF-Met and angiogenesis.
    Matsumoto K; Nakamura T
    Front Biosci; 2008 Jan; 13():1943-51. PubMed ID: 17981681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor.
    Date K; Matsumoto K; Kuba K; Shimura H; Tanaka M; Nakamura T
    Oncogene; 1998 Dec; 17(23):3045-54. PubMed ID: 9881707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Met/HGF receptor and angiogenesis by NK4 leads to suppression of tumor growth and migration in malignant pleural mesothelioma.
    Suzuki Y; Sakai K; Ueki J; Xu Q; Nakamura T; Shimada H; Nakamura T; Matsumoto K
    Int J Cancer; 2010 Oct; 127(8):1948-57. PubMed ID: 20104519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of transferred NK4 gene on biological characteristics of human pancreatic cancer cell line SW1990].
    Lai RX; Yuan SZ; Nakamura T
    Ai Zheng; 2004 Oct; 23(10):1134-8. PubMed ID: 15473922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nk4, a new HGF/SF variant, is an antagonist to the influence of HGF/SF on the motility and invasion of colon cancer cells.
    Parr C; Hiscox S; Nakamura T; Matsumoto K; Jiang WG
    Int J Cancer; 2000 Feb; 85(4):563-70. PubMed ID: 10699931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of PI3K and ERK1/2 pathways in hepatocyte growth factor-induced cholangiocarcinoma cell invasion.
    Menakongka A; Suthiphongchai T
    World J Gastroenterol; 2010 Feb; 16(6):713-22. PubMed ID: 20135719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of HGF/SF-induced breast cancer cell motility and invasion by the HGF/SF variant, NK4.
    Hiscox S; Parr C; Nakamura T; Matsumoto K; Mansel RE; Jiang WG
    Breast Cancer Res Treat; 2000 Feb; 59(3):245-54. PubMed ID: 10832594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of mesothelioma cancer stem-like cells with adenovirus-mediated NK4 gene therapy.
    Deng XB; Xiao L; Wu Y; Jin F; Mossman B; Testa JR; Xiao GH
    Int J Cancer; 2015 Jul; 137(2):481-90. PubMed ID: 25501304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [NK4 growth inhibition of human Raji lymphoma xenografts by competitive interrupting HGF/Met signal pathway].
    Gao Z; Zheng X; Shen R; Zhao H; Cen D; Luo J; Hua S; Pei R; Lyu J
    Zhonghua Bing Li Xue Za Zhi; 2014 Aug; 43(8):551-5. PubMed ID: 25346127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of angiogenesis and HGF-cMET-elicited malignant processes in human hepatocellular carcinoma cells using adenoviral vector-mediated NK4 gene therapy.
    Heideman DA; Overmeer RM; van Beusechem VW; Lamers WH; Hakvoort TB; Snijders PJ; Craanen ME; Offerhaus GJ; Meijer CJ; Gerritsen WR
    Cancer Gene Ther; 2005 Dec; 12(12):954-62. PubMed ID: 15905856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4.
    Matsumoto K; Nakamura T; Sakai K; Nakamura T
    Proteomics; 2008 Aug; 8(16):3360-70. PubMed ID: 18646008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
    Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
    Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, a HGF/SF antagonist.
    Martin TA; Parr C; Davies G; Watkins G; Lane J; Matsumoto K; Nakamura T; Mansel RE; Jiang WG
    Carcinogenesis; 2003 Aug; 24(8):1317-23. PubMed ID: 12807719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NK4 gene expression enhances 5-fluorouracil-induced apoptosis of murine colon cancer cells.
    Taiyoh H; Kubota T; Fujiwara H; Matsumura A; Murayama Y; Okamoto K; Ichikawa D; Ochiai T; Nakamura T; Matsumoto K; Nakamura T; Otsuji E
    Anticancer Res; 2011 Jun; 31(6):2217-24. PubMed ID: 21737644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of transferred NK4 gene on proliferation, migration, invasion and apoptosis of human prostate cancer DU145 cells.
    Yue D; Wang Y; Ma P; Li YY; Chen H; Wang P; Ren CS
    Asian J Androl; 2010 May; 12(3):381-9. PubMed ID: 20400971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte nuclear factor 6 inhibits the growth and metastasis of cholangiocarcinoma cells by regulating miR-122.
    Zhu H; Mi Y; Jiang X; Zhou X; Li R; Wei Z; Jiang H; Lu J; Sun X
    J Cancer Res Clin Oncol; 2016 May; 142(5):969-80. PubMed ID: 26825606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting c-MET by Tivantinib through synergistic activation of JNK/c-jun pathway in cholangiocarcinoma.
    Wei K; Li M; Zöller M; Wang M; Mehrabi A; Hoffmann K
    Cell Death Dis; 2019 Mar; 10(3):231. PubMed ID: 30850583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.